Player FM - Internet Radio Done Right
28 subscribers
Checked 5d ago
เพิ่มแล้วเมื่อ fourปีที่ผ่านมา
Konten disediakan oleh The Lancet and The Lancet Neurology. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh The Lancet and The Lancet Neurology atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Player FM - Aplikasi Podcast
Offline dengan aplikasi Player FM !
Offline dengan aplikasi Player FM !
Podcast Layak Disimak
DISPONSORI
S
Squid Game: The Official Podcast
Squid Game is back, and so is Player 456. In the gripping Season 2 premiere, Player 456 returns with a vengeance, leading a covert manhunt for the Recruiter. Hosts Phil Yu and Kiera Please dive into Gi-hun’s transformation from victim to vigilante, the Recruiter’s twisted philosophy on fairness, and the dark experiments that continue to haunt the Squid Game. Plus, we touch on the new characters, the enduring trauma of old ones, and Phil and Kiera go head-to-head in a game of Ddakjji. Finally, our resident mortician, Lauren Bowser is back to drop more truth bombs on all things death. SPOILER ALERT! Make sure you watch Squid Game Season 2 Episode 1 before listening on. Let the new games begin! IG - @SquidGameNetflix X (f.k.a. Twitter) - @SquidGame Check out more from Phil Yu @angryasianman , Kiera Please @kieraplease and Lauren Bowser @thebitchinmortician on IG Listen to more from Netflix Podcasts . Squid Game: The Official Podcast is produced by Netflix and The Mash-Up Americans.…
In conversation with... Beau Ances
Manage episode 349600423 series 2902412
Konten disediakan oleh The Lancet and The Lancet Neurology. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh The Lancet and The Lancet Neurology atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Beau Ances (Washington University in St Louis, MO, USA) discusses recent research on amyloid biomarkers in people with genetic forms of Alzheimer’s disease; his Article is published in the January issue of The Lancet Neurology.
200 episode
Manage episode 349600423 series 2902412
Konten disediakan oleh The Lancet and The Lancet Neurology. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh The Lancet and The Lancet Neurology atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Beau Ances (Washington University in St Louis, MO, USA) discusses recent research on amyloid biomarkers in people with genetic forms of Alzheimer’s disease; his Article is published in the January issue of The Lancet Neurology.
200 episode
Semua episode
×L
Listen to The Lancet Neurology
1 In conversation with... Elizabeth Finger 17:43
17:43
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
17:43In this podcast, linked to the February 2025 issue of The Lancet Neurology , Elena Becker-Barroso (Editor-in-Chief) chats to Elizabeth Finger (Western University, London, ON, Canada) about the FOXY trial of oxytocin for apathy in people with frontotemporal dementia.
L
Listen to The Lancet Neurology
1 The Lancet Neurology Editors on advances in neurology in 2024 17:30
17:30
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
17:30The Lancet Neurology Editors take a look back at advances in neurology in 2024, as highlighted by experts in a series of Round-ups published in the January issue.
L
Listen to The Lancet Neurology
1 In conversation with... Florian Krismer and Elizabeth Coon 17:14
17:14
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
17:14Florian Krismer (Innsbruck Medical University) and Elizabeth Coon (Mayo Clinic) join Sarah Passey ( The Lancet Neurology) to discuss their Review paper on multiple system atrophy, which is published in the December issue of The Lancet Neurology.
L
Listen to The Lancet Neurology
Professor Suvankar Pal (University of Edinburgh) joins Sarah Passey (Senior Editor at The Lancet Neurology ) to discuss the first findings from the MND-SMART trial of treatments for motor neuron disease. The Article is published in the November issue of The Lancet Neurology .
L
Listen to The Lancet Neurology
1 In conversation with... Jorge Correale and Lilyana Amezcua 19:00
19:00
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
19:00Prof Jorge Correale and Dr Lilyana Amezcua talk to The Lancet Neurology about their Personal View papers, published in the October 2024 issue, on the differential diagnosis of multiple sclerosis in regions outside North America and Western Europe and in people from minority ethnic or racial backgrounds in North America, northern Europe, and Australasia.…
L
Listen to The Lancet Neurology
Dr Alex Iranzo joins The Lancet Neurology to discuss his recent Review on the association between sleep disorders and Parkinson's disease. The Review is published in the August issue of The Lancet Neurology .
L
Listen to The Lancet Neurology
Dr Adrian Owen joins Sarah Passey to chat about a his Personal View, published in the August 2024 issue of The Lancet Neurology , about detecting awareness after an acute brain injury.
L
Listen to The Lancet Neurology
1 In conversation with... Glenn Nielsen 15:28
15:28
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
15:28Dr Glenn Nielsen joins Lauren Southwell to discuss the Physio4FMD trial of specialist physiotherapy for people with functional motor disorder in England and Scotland. This Article is published in the July issue of The Lancet Neurology.
L
Listen to The Lancet Neurology
1 In conversation with... Sanjay Sisodiya 20:48
20:48
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
20:48Sanjay Sisodiya joins The Lancet Neurology to discuss the potential effects of climate change on brain health. The Personal View is published in the June issue of The Lancet Neurology .
L
Listen to The Lancet Neurology
1 In conversation with... Jacqueline French and Jacob Pellinen 23:28
23:28
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
23:28Jacqueline French and Jacob Pellinen join Senior Editor Sarah Passey to discuss recent progress made in the diagnosis of epilepsy and challenges that remain. Their Review on this topic is published in the May issue of The Lancet Neurology.
L
Listen to The Lancet Neurology
1 In conversation with... Jaimie Steinmetz, Theo Vos, Katrin Seeher and Tarun Dua 25:18
25:18
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
25:18Jaimie Steinmetz and Theo Vos from the Institute of Health Metrics and Katrin Seeher and Tarun Dua from WHO join Heather Brown and Lauren Southwell to discuss new data on the global, regional, and national burden of disorders affecting the nervous system. The Article is published in the April issue of The Lancet Neurology .…
L
Listen to The Lancet Neurology
1 In conversation with... Giovanni Frisoni 12:20
12:20
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
12:20Giovanni Frisoni joins The Lancet Neurology to discuss new European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders. The Personal View is published in the March issue of The Lancet Neurology .
L
Listen to The Lancet Neurology
1 In conversation with... Marianne Chapleau and Gil Rabinovici 21:45
21:45
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
21:45Marianne Chapleau and Gil Rabinovici join Senior Editor Sarah Passey to discuss their research on posterior cortical atrophy. The Article is published in the February issue of The Lancet Neurology .
L
Listen to The Lancet Neurology
1 In conversation with... Cecilia Åkerlund and David Nelson 18:24
18:24
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
18:24Cecilia Åkerlund and David Nelson join The Lancet Neurology to discuss their research on clinical variables that might distinguish how the disease process progresses in people with traumatic brain injury. The Article is published in the January issue of The Lancet Neurology.
L
Listen to The Lancet Neurology
1 In conversation with... Rustam Al-Shahi Salman 24:09
24:09
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
24:09Rustam Al-Shahi Salman joins Senior Editor Sarah Passey to discuss the COCROACH meta-analysis findings, published in the December issue of The Lancet Neurology , of the effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage.
L
Listen to The Lancet Neurology
1 In conversation with... Njideka Okubadejo and Mie Rizig 26:34
26:34
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
26:34Njideka Okubadejo and Mie Rizig join The Lancet Neurology to discuss their comprehensive genome-wide assessment in African and African admixed individuals with the aim of developing a better understanding of the genetic architecture of Parkinson's disease in these underserved populations.
L
Listen to The Lancet Neurology
1 In conversation with... Anthony Feinstein 14:42
14:42
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
14:42Anthony Feinstein (University of Toronto and Sunnybrook Health Sciences Centre, Toronto, Canada) discusses CogEx, a randomised trial of cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis. The Article is published in the October issue of The Lancet Neurology .…
L
Listen to The Lancet Neurology
1 In conversation with... William Jagust 13:36
13:36
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
13:36William Jagust (University of California in Berkeley, CA, USA) talks to Senior Editor Sarah Passey about the complex pathway between amyloid β and cognition, and implications for therapy for people with Alzheimer’s disease. His Personal View on this topic is published in the September issue of The Lancet Neurology .…
L
Listen to The Lancet Neurology
1 In conversation with... Stephen Strittmatter 14:34
14:34
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
14:34Stephen Strittmatter (Yale School of Medicine, CT, USA) discusses his first-in-human and randomised trial of a soluble Nogo-receptor-Fc decoy in patients with chronic cervical spinal cord injury. The Article is published in the August issue of The Lancet Neurology .
L
Listen to The Lancet Neurology
1 In conversation with... Benzi Kluger, Claire Creutzfeldt, and Malenna Sumrall 17:20
17:20
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
17:20Benzi Kluger (University of Rochester Medical Center, Rochester, NY, USA), Claire Creutzfeldt (University of Washington, Seattle, WA, USA), and Malenna Sumrall (University of Colorado Anschutz Medical Campus, Aurora, CO, USA) join Jonathan Blott to discuss palliative care for individuals with neurological diseases, exploring the challenges and opportunities in enhancing the quality of life for those affected by neurological conditions. Their Review is published in the July issue of The Lancet Neurology .…
L
Listen to The Lancet Neurology
Andrew Cole (Massachusetts General Hospital Epilepsy Service, Boston, MA, USA) talks to Senior Editor Sarah Passey about the complexities underlying epilepsy in people with glioblastoma. His Review on this topic is published in the June issue of The Lancet Neurology.
L
Listen to The Lancet Neurology
1 In conversation with... Karen Duff and Connor Langworth-Green 15:20
15:20
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
15:20Karen Duff and Connor Langworth-Green (University College London, London, UK) discuss tauopathies and the chronic effects of inflammation on this group of disorders. Their Personal View on this topic is published in the May issue of The Lancet Neurology .
L
Listen to The Lancet Neurology
1 In conversation with... Kerstin Hellwig 14:24
14:24
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
14:24Kerstin Hellwig (Ruhr University Bochum, Bochum, Germany) discusses family planning considerations in multiple sclerosis. This Review is published in the April issue of The Lancet Neurology .
L
Listen to The Lancet Neurology
1 In conversation with... Geraldine Dawson 24:34
24:34
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
24:34Geraldine Dawson (Duke University School of Medicine, NC, USA) discusses the latest advances and ongoing challenges in prediction of autism during infancy. This Review is published in the March issue of The Lancet Neurology .
L
Listen to The Lancet Neurology
1 In conversation with... Ellisiv Mathiesen 8:45
8:45
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
8:45Ellisiv Mathiesen (The University of Tromsø – the Arctic University of Norway, Tromsø, Norway) discusses the findings of the TWIST trial, which investigated the use of tenecteplase for patients with wake-up stroke who were selected for treatment by non-contrast CT. This Fast-track Article is published in the February issue of The Lancet Neurology .…
L
Listen to The Lancet Neurology
Beau Ances (Washington University in St Louis, MO, USA) discusses recent research on amyloid biomarkers in people with genetic forms of Alzheimer’s disease; his Article is published in the January issue of The Lancet Neurology .
L
Listen to The Lancet Neurology
Axel Petzold (National Hospital for Neurology and Neurosurgery and Moorfields Eye Hospital, London, UK, and Amsterdam University Medical Center, Amsterdam, Netherlands) discusses a Position Paper, published in the December issue of The Lancet Neurology , which sets out new criteria for the diagnosis and classification of optic neuritis.…
L
Listen to The Lancet Neurology
1 In conversation with... Maeike Zijlmans 14:37
14:37
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
14:37Maeike Zijlmans (University Medical Center Utrecht, Utrecht, Netherlands) discusses recent research on tailoring of epilepsy surgery with biomarkers on intraoperative electrocorticography, and describes some of the challenges of this technique and what the future steps are for the field.
L
Listen to The Lancet Neurology
1 In conversation with... Jerome Siegel 43:50
43:50
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
43:50Jerome Siegel (University of California, Los Angeles, CA, USA) discusses sleep research in hunter-gatherer populations and what we can learn from the sleep habits of various species; his Review is published in the October issue of The Lancet Neurology , which is the fourth paper in The Lancet’ s Series on sleep and sleep disorders.…
Laurent Servais and Dora Markati (both from the University of Oxford, UK) discuss emerging therapies for Duchenne muscular dystrophy; their Review is published in the September issue of The Lancet Neurology.
L
Listen to The Lancet Neurology
1 In conversation with... Andreas Charidimou 22:58
22:58
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
22:58Andreas Charidimou (Massachusetts General Hospital, Boston, MA, USA) discusses an international collaborative study that presents new Boston criteria for diagnosis of cerebral amyloid angiopathy; the Article is published in the August issue of The Lancet Neurology .
L
Listen to The Lancet Neurology
1 In conversation with... Sarah Tabrizi and Cristina Sampaio 18:52
18:52
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
18:52Sarah Tabrizi (UCL Queen Square Institute of Neurology, London, UK) and Cristina Sampaio (CHDI Foundation, Princeton, NJ, USA) discuss two papers on Huntington’s disease published in the July issue of The Lancet Neurology : a Position Paper outlining a new classification of the disease, called the Huntington’s Disease Integrated Staging System, and a Personal View on potential disease-modifying therapies.…
L
Listen to The Lancet Neurology
Mark Hallett (National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA) discusses his Review, published in the June issue of The Lancet Neurology , on functional neurological disorder, and talks about new subtypes of this disorder, diagnostic challenges, and how education is important.…
L
Listen to The Lancet Neurology
Eva Feldman (University of Michigan, Ann Arbor, USA) discusses the latest advances in the genetics, risk factors, pathophysiology, therapeutic development, and the diagnosis and prognosis of amyotrophic lateral sclerosis; the Series is published in the May issue of The Lancet Neurology.
L
Listen to The Lancet Neurology
1 In conversation with... Estrella Morenas-Rodriguez and Christian Haass 27:15
27:15
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
27:15Estrella Morenas-Rodriguez and Christian Haass (German Centre for Neurodegenerative Diseases, Munich, Germany) discuss their recent research, published in the April issue of The Lancet Neurology , on soluble TREM2 and its association with Alzheimer’s disease biomarkers and cognition.
L
Listen to The Lancet Neurology
1 In conversation with... John Collinge 14:45
14:45
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
14:45John Collinge (MRC Prion Unit, University College London, London, UK) discusses a first-in-human treatment programme to give PRN100, an anti-prion-protein monoclonal antibody, to patients with Creutzfeldt–Jakob disease; the report is published in the April issue of The Lancet Neurology .
L
Listen to The Lancet Neurology
Alexandra Durr (Paris Brain Institute, Pitié-Salpêtrière Paris, France) discusses the ATRIL study, a randomised trial of riluzole in patients with spinocerebellar ataxia type 2, which is published in the March issue of The Lancet Neurology.
L
Listen to The Lancet Neurology
1 In conversation with... Giuseppe Citerio 9:35
9:35
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
9:35Giuseppe Citerio (University of Milano-Bicocca, Milan, Italy) discusses the implications of a study from the CENTER-TBI project of the effect of frailty on 6-month outcome after traumatic brain injury, which is published in the February issue of The Lancet Neurology .
L
Listen to The Lancet Neurology
1 In conversation with... Alberto Costa 15:14
15:14
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
15:14Alberto Costa (Case Western Reserve University, Cleveland, OH, USA) discusses his study on the use of memantine in adolescents and young adults with Down syndrome, which is published in the January issue of The Lancet Neurology .
L
Listen to The Lancet Neurology
1 In conversation with... Olivier Rascol 28:27
28:27
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
28:27Olivier Rascol (Toulouse University, France) discusses the uses of amantadine in the treatment of patients with movement disorders, which are the focus of his Personal View in the December issue of The Lancet Neurology.
L
Listen to The Lancet Neurology
Antonio Uccelli (University of Genoa) discusses his research, published in the November issue of The Lancet Neurology , on the therapeutic use of mesenchymal stem cells for multiple sclerosis.
L
Listen to The Lancet Neurology
Priya Palta (Columbia University, New York) explains the importance of blood pressure control in the prevention of cognitive decline. Her Review, published in the October issue of The Lancet Neurology , provides an update of the mounting evidence that links hypertension with dementia risk.
L
Listen to The Lancet Neurology
Adam Boxer (University of California, San Francisco) discusses his research, published in the September issue of The Lancet Neurology , on diagnostic performance of tau biomarkers in neurodegenerative diseases.
L
Listen to The Lancet Neurology
Irene Cortese (National Institute of Neurological Disorders and Stroke) discusses the difficulties of designing clinical trials in progressive multifocal leukoencephalopathy.
L
Listen to The Lancet Neurology
1 In conversation with... Doug Turnbull 20:12
20:12
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
20:12Doug Turnbull (University of Newcastle) discusses mitochondrial diseases in adults, which are reviewed in the July issue of The Lancet Neurology , and explains how important these diseases are for neurologists.
L
Listen to The Lancet Neurology
1 In conversation with... Geert Jan Biessels 7:59
7:59
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
7:59Geert Jan Biessels (University Medical Centre Utrecht) discusses his research, published in The Lancet Neurology June issue, on using strategic infarct locations to predict post-stroke cognitive impairment.
L
Listen to The Lancet Neurology
1 In Conversation With... Henk-Jan Westeneng 8:36
8:36
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
8:36Henk-Jan Westeneng discusses his new work on the causal effects of pre-symptomatic lifestyle on ALS.
L
Listen to The Lancet Neurology
Bruce Campbell joins The Lancet Neurology to discuss his systematic review of the HERMES collaboration.
L
Listen to The Lancet Neurology
1 In Conversation With... Anne MacGregor 12:50
12:50
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
12:50Anne MacGregor discusses her recent Review of menstrual migraine, and explains why this disease needs greater recognition.
L
Listen to The Lancet Neurology
Peter Rothwell (Oxford University) discusses his new research, found in our new issue, on asymptomatic carotid stenosis and stroke.
L
Listen to The Lancet Neurology
1 Spinal cord injury and degenerative cervical myelopathy 19:33
19:33
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
19:33Professor Michael Fehlings discusses the implications of his two papers in the Feb 2021 issue of The Lancet Neurology .
L
Listen to The Lancet Neurology
Emma Jones and Simon Mead discuss their article in The Lancet Neurology , identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease.
L
Listen to The Lancet Neurology
1 Prednisone in short-term prevention of cluster headache 9:09
9:09
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
9:09Mark Obermann discusses his study examining the use of prednisone for the short-term prevention of cluster headache.
L
Listen to The Lancet Neurology
1 PET imaging of inflammation in neurological and psychiatric disorders 9:11
9:11
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
9:11Robert Innis discusses his work on measuring neuroinflammation using PET imaging.
L
Listen to The Lancet Neurology
1 Neurological associations of COVID-19 11:23
11:23
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
11:23Tom Solomon discusses his Rapid Review on neurologically-associated COVID-19 problems, in The Lancet Neurology.
L
Listen to The Lancet Neurology
1 Advances in understanding of Rett syndrome 20:44
20:44
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
20:44Huda Zoghbi discusses the prospects for future therapies in Rett syndrome.
L
Listen to The Lancet Neurology
Bas Bloem chats about his new research into a network model for reshaping chronic neurological care for patients with Parkinson's disease.
L
Listen to The Lancet Neurology
1 Optimal time to treat Huntington's Disease 12:55
12:55
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
12:55Sarah Tabrizi discusses her new research into analysing the early onset of Huntington's Disease.
L
Listen to The Lancet Neurology
1 Evidence-based support for autistic people across the lifespan 21:14
21:14
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
21:14Meng-Chuan Lai discusses the current evidence base for supporting autistic people.
L
Listen to The Lancet Neurology
Tobias Derfuss discusses his rapid review on advances in oral immunomodulating therapies in relapsing multiple sclerosis.
L
Listen to The Lancet Neurology
1 The global burden of neurological conditions 37:11
37:11
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
37:11Andrea Winkler discusses the global burden caused by stroke, epilepsy, dementia, and neuroinfections, and what low- and middle-income countries can do.
L
Listen to The Lancet Neurology
Jonathan Schott discusses the associations between blood pressure across adulthood and late-life brain structure and pathology.
L
Listen to The Lancet Neurology
Jeffrey Wozniak talks about his Review in The Lancet Neurology , on clinical presentation, diagnosis, and management of fetal alcohol spectrum disorder.
L
Listen to The Lancet Neurology
Martin Dichgans discusses advancements in the field of stroke genetics.
L
Listen to The Lancet Neurology
1 Next-generation sequencing and clinical neurology 7:46
7:46
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
7:46Brent Fogel talks to The Lancet Neurology about his work on large-scale genomic analysis.
L
Listen to The Lancet Neurology
1 Role of astroglia in Alzheimer's disease 15:04
15:04
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
15:04Amaia Arranz and Bart De Strooper discuss their Review on the role of astroglia in Alzheimer's disease.
L
Listen to The Lancet Neurology
Michael Irwin (University of California, Los Angeles, USA) discusses a Review concerning potential links of sleep disturbance and possible increased risk of Alzheimer's disease dementia.
L
Listen to The Lancet Neurology
Lindsay Wallace and Kenneth Rockwood join The Lancet Neurology to talk about their work on the association between frailty and the onset of Alzheimer's disease.
L
Listen to The Lancet Neurology
In the latest podcast from The Lancet Neurology , Jan Scheitz discusses the development of stroke–heart syndrome.
L
Listen to The Lancet Neurology
Mark Cook and Phillippa Karoly join The Lancet Neurology to discuss their retrospective study of cyclical patterns in epileptic seizures.
L
Listen to The Lancet Neurology
1 Cerebral white matter demyelination in multiple sclerosis 15:30
15:30
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
15:30Bruce Trapp and Daniel Ontaneda discuss their retrospective study investigating cortical neuronal loss and cerebral white-matter demyelination in mulitple sclerosis.
L
Listen to The Lancet Neurology
1 Autoimmune encephalitis after herpes simplex encephalitis 10:29
10:29
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
10:29Josep Dalmau joins The Lancet Neurology to discuss recognition and outcomes of autoimmune encephalitis after herpes simplex encephalitis.
L
Listen to The Lancet Neurology
David Eidelberg and Katharina Schindelbeck join The Lancet Neurology to explain their new review of the applications of network imaging biomarkers in Parkinson's disease.
L
Listen to The Lancet Neurology
1 Progressive multifocal leukoencephalopathy 19:45
19:45
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
19:45Eugene Major and David Clifford join The Lancet Neurology to discuss their review of pathogenesis and treatments for progressive multifocal leukoencephalopathy.
L
Listen to The Lancet Neurology
1 Antiepileptic drugs and risk of congenital malformation 7:57
7:57
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
7:57Torbjörn Tomson discusses the issue of antiepileptic drugs during pregnancy and the risk of major congenital malformations.
L
Listen to The Lancet Neurology
1 Global burden of stroke: The Lancet Neurology: June 22, 2016 11:05
11:05
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
11:05Professor Valery Feigin discusses an Article on the global burden of stroke and risk factors from 1990–2013.
L
Listen to The Lancet Neurology
1 Stakeholder cooperation in orphan drug development: The Lancet Neurology: June 6, 2016 11:20
11:20
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
11:20Annemieke Aartsma-Rus and Elizabeth Vroom discuss with Patricia Lobo the developments in Duchenne muscular dystrophy therapy and how this can serve as a paradigm for development of treatment for rare diseases.
L
Listen to The Lancet Neurology
1 The Lancet Neurology Conference: Preclinical neurodegenerative disease: towards prevention and early diagnosis 12:46
12:46
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
12:46Richard Lane interviews John Hardy, Jonathan Rohrer and Sarah Tabrizi, who are members of the Scientific Committee.
L
Listen to The Lancet Neurology
1 World encephalitis day: The Lancet Neurology: February 22, 2016 16:21
16:21
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
16:21Francesc Graus and Josep Dalmau discuss new criteria for a clinical approach for the diagnosis of autoimmune encephalitis.
L
Listen to The Lancet Neurology
1 Cerebral cavernous malformations: The Lancet Neurology: February 2016 11:44
11:44
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
11:44Rustam Salman discusses how the assessment of cerebral cavernous malformations can help identify people at risk of subsequent brain haemorrhage.
L
Listen to The Lancet Neurology
1 ParkinsonNet: The Lancet Neurology: January 8, 2016 21:21
21:21
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
21:21Bas Bloem talks about ParkinsonNet, a healthcare model that supports a multidisciplinary network for people with Parkinson’s disease.
L
Listen to The Lancet Neurology
1 Biomarkers and dementia: The Lancet Neurology: Jan 2016 18:33
18:33
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
18:33Clifford Jack from the Mayo Clinic discusses a research article which investigates the role of biomarkers to help identify preclinical dementia.
L
Listen to The Lancet Neurology
1 Diaphragm pacing for ALS: The Lancet Neurology: July 31, 2015 14:45
14:45
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
14:45Chris McDermott and Richard Lane discuss the DiPALS study, investigating the effect of diaphragm pacing in addition to non-invasive ventilation in patients with ALS.
L
Listen to The Lancet Neurology
1 Endovascular stent thrombectomy: The Lancet Neurology: July 13, 2015 9:38
9:38
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
9:38Bruce Campbell discusses the remarkable benefits of endovascular treatment for ischaemic stroke.
L
Listen to The Lancet Neurology
1 Lower urinary tract dysfunction: The Lancet Neurology: June 16, 2015 23:46
23:46
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
23:46Jalesh Panicker discusses lower urinary tract dysfunction, a common problem in people with neurological disorders.
L
Listen to The Lancet Neurology
1 Status epilepticus: The Lancet Neurology: June 1, 2015 9:43
9:43
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
9:43Daniel Lowenstein discusses research into status epilepticus.
L
Listen to The Lancet Neurology
1 Apathy in Parkinson's disease: The Lancet Neurology: April 21, 2015 16:20
16:20
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
16:20Paul Krack discusses apathy in Parkinson's disease.
L
Listen to The Lancet Neurology
1 Neuroinflammation in Alzheimer’s disease: The Lancet Neurology: March 16, 2015 13:12
13:12
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
13:12In an interview Michael Heneka considers the contribution of neuroinflammatory mechanisms to Alzheimer’s disease pathogenesis.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: February 16, 2015 10:06
10:06
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
10:06Steven Goodrick talks to Jonathan Rohrer about the latest research in C9orf72 expansions.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: January 16, 2015 14:41
14:41
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
14:41Alan Thompson and Steven Goodrick discuss a new three-part Series on progressive MS.
L
Listen to The Lancet Neurology
1 Seizure detection and reporting in epilepsy: The Lancet Neurology: February 13, 2018 6:03
6:03
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
6:03Christian Elger discusses the diagnostic challenges in epilepsy with the detection and reporting of seizures.
L
Listen to The Lancet Neurology
1 MS McDonald criteria revisions: The Lancet Neurology: February 2018 9:01
9:01
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
9:01Jeffrey Cohen joins us to talk about the process of updating and revising the McDonald criteria for diagnosis of MS.
L
Listen to The Lancet Neurology
1 GWAS on dementia with Lewy bodies: The Lancet Neurology: January, 2018 6:18
6:18
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
6:18Jose Bras discusses his study of the genetic architecture of dementia with Lewy bodies.
L
Listen to The Lancet Neurology
1 Traumatic Brain Injury: The Lancet Neurology: November 7, 2017 37:30
37:30
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
37:30Andrew Maas and David Menon, lead authors, discuss The Lancet Neurology Commission on traumatic brain injury and outline the worldwide burden.
L
Listen to The Lancet Neurology
1 TDP-43 and Alzheimer's disease: The Lancet Neurology: November 2017 9:09
9:09
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
9:09Keith Josephs talks about considering TDP-43 as a potential factor related to increased rates of hippocampal atrophy in patients with Alzheimer's disease.
L
Listen to The Lancet Neurology
1 Biomarkers in stroke recovery: The Lancet Neurology: October 2017 7:00
7:00
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
7:00Cathy Stinear discusses her review of biomarkers that might predict motor recovery after stroke.
L
Listen to The Lancet Neurology
1 Genetic variants and Huntington's: The Lancet Neurology: September 2017 18:40
18:40
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
18:40Lesley Jones and Sarah Tabrizi talk about their work on the identification of genetic markers associated with the progression of Huntington's disease.
L
Listen to The Lancet Neurology
1 Simvastatin and MS: The Lancet Neurology: August 2017 4:50
4:50
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
4:50Jeremy Chataway discusses the surprising effects of simvastatin on patients with secondary progressive multiple sclerosis.
L
Listen to The Lancet Neurology
1 Progressive supranuclear palsy: The Lancet Neurology: July 2017 24:27
24:27
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
24:27Adam Boxer offers an overview of the latest on diagnosis and treatment for progressive supranuclear palsy.
L
Listen to The Lancet Neurology
1 Neurological consequences of obesity: The Lancet Neurology: May 9, 2017 9:53
9:53
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
9:53Eva Feldman discusses the neurological consequences of obesity.
L
Listen to The Lancet Neurology
1 Neurodegenerative disease: The Lancet Neurology: February 23, 2017 21:10
21:10
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
21:10Marc Diamond discusses his Personal View on the prion model for progression and diversity of neurodegenerative diseases.
L
Listen to The Lancet Neurology
1 Autosomal dominant familial Alzheimer's disease: The Lancet Neurology: 21 October 2016 21:15
21:15
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
21:15Randall Bateman and Nick Fox discuss what they've learned from their papers on Alzheimer's disease.
L
Listen to The Lancet Neurology
1 Ventilation for ALS patients: The Lancet Neurology: November 2016 9:40
9:40
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
9:40Professor Thomas Similowski discusses his surprising study on the effectiveness of non-invasive ventilation for patients with amyotrophic lateral sclerosis.
L
Listen to The Lancet Neurology
1 Sleep disorders in children: The Lancet Neurology: September 12, 2016 6:08
6:08
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
6:08Dr. Kiran Maski discusses insomnia, parasomnia, and narcolepsy in children.
L
Listen to The Lancet Neurology
1 Non-immersive Virtual Reality Exercise in Stroke Rehabilitation 7:57
7:57
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
7:57Dr. Gustavo Saposnik discusses the efficacy of non-immersive virtual reality exercise in the treatment of stroke.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: December 8, 2014 10:55
10:55
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
10:55Gabrielle deVeber discusses a Review on childhood stroke.
L
Listen to The Lancet Neurology
Jonathan Smith discusses how assessment of pain in elderly adults with dementia differs from that in healthy elderly adults.
L
Listen to The Lancet Neurology
Professor Ammar Al-Chalabi discusses a population based modelling study of the development of amyotrophic lateral sclerosis.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: September 15, 2014 6:27
6:27
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
6:27Steven Galetta discusses his Review on how tests of visual function can be useful in the assessment of minor head injury and TBI.
L
Listen to The Lancet Neurology
Sir Graham Teasdale reflects on the Glasgow COMA scale for brain injury, 40 years after it was published in The Lancet.
L
Listen to The Lancet Neurology
John Hardy discusses a genome-wide association study on frontotemporal dementia and its subtypes.
L
Listen to The Lancet Neurology
David Bennett discusses painful and painless channelopathies.
L
Listen to The Lancet Neurology
Dr. David McDonagh and Professor Mark Newman discuss the neurological complications of cardiac surgery.
L
Listen to The Lancet Neurology
Craig Anderson discusses findings from a study about the effects of blood pressure variability on outcomes for patients with intracerebral haemorrhage.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: January 20, 2014 16:08
16:08
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
16:08Henrik Hagberg discusses the role of mitochondria in CNS development and in the injury responses of the developing brain.
L
Listen to The Lancet Neurology
Finbar O'Callaghan from the Institute for Child Health, London, discusses new research about the incidence and risk factors for childhood stroke.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: November 11, 2013 36:59
36:59
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
36:59In an extended interview, Nicholas Abend from the Children's Hospital of Philadelphia discusses a Review on electrographic seizures and status epilepticus in critically ill children and neonates with encephalopathy.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: September 17, 2013 6:58
6:58
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
6:58Hugh Marcus from the University of Cambridge discussing a Review on stroke and TIA in the posterior territory.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: August 08, 2013 17:09
17:09
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
17:09Francisco Javier Carod-Artal discusses a Review concerning the neurological complications of dengue virus infection.
L
Listen to The Lancet Neurology
Paul Hagerman discusses a Review which highlights the latest clinical and molecular understanding of the FMR1 mutation and FXTAS.
L
Listen to The Lancet Neurology
Sarah Tabrizi discusses the latest findings of the TRACK HD study concerning Huntington's disease.
L
Listen to The Lancet Neurology
Klaus Fassbender discusses a Review about streamlining pre-hospital management of stroke.
L
Listen to The Lancet Neurology
Joanna Wardlaw discusses the poorly understood condition of cerebral small vessel disease.
L
Listen to The Lancet Neurology
Jim Barkovich from UCSF discusses a Review about midbrain and hindbrain disorders.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: February 13, 2013 14:02
14:02
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
14:02Kim Meador explains the effects of fetal exposure to anti-epileptic drugs, plus other highlights from the March issue.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: January 16, 2013 12:59
12:59
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
12:59Josep Dalmau describes the clinical and pathological features of anti-NMDA receptor encephalitis.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: December 07, 2012 11:41
11:41
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
11:41Roger Barker discusses fetal dopaminergic transplantation as a therapeutic option for Parkinson's disease.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: November 15, 2012 12:06
12:06
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
12:06Eric Reiman discusses a research article, where biomarker changes are assessed in early onset Alzheimer's disease.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: October 29, 2012 12:47
12:47
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
12:47Marjo van der Knaap discusses megalencephalic leukoencephalopathy with subcortical cysts.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: September 18, 2012 10:52
10:52
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
10:52Bjarne Udd discusses the myotonic dystrophies.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: August 13, 2012 18:42
18:42
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
18:42Frank Gilliam discusses the adverse effects of anti-epileptic drugs.
L
Listen to The Lancet Neurology
Highlights from the August issue, and Dag Aarsland discusses dementia in patients with Parkinson's disease.
L
Listen to The Lancet Neurology
Justin McArthur discusses CNS opportunistic infections within the context of HIV.
L
Listen to The Lancet Neurology
Brian Callaghan discusses a Review about diabetic neuropathy.
L
Listen to The Lancet Neurology
Hudson Freeze discusses a Review about the neurology of inherited glycosilation disorders.
L
Listen to The Lancet Neurology
Peter Langhorne discusses the potential of specialist stroke units in low and middle-income settings.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: February 16, 2012 11:46
11:46
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
11:46Kailash P Bhatia discusses a Review on the epidemiology, clinical features, diagnosis, and treatment of functional movement disorders.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: January 18, 2012 11:25
11:25
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
11:25Discussion of a Review about posterior cortical atrophy, and other issue highlights.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: December 12, 2011 20:09
20:09
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
20:09Discussion of the links between nutrition and stroke risk.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: November 11, 2011 13:49
13:49
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
13:49Brenda Banwell discusses the potential of MRI screening after a first demyelinating event as a future predictor of MS in children.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: October 17, 2011 16:03
16:03
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
16:03Chris Polman discusses a Rapid Review of new oral therapies for patients with multiple sclerosis.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: September 19, 2011 10:56
10:56
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
10:56Ashfaq Shuaib talks about collateral blood flow in the brain as a potential therapeutic target for patients with acute ischaemic.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: August 15, 2011 15:19
15:19
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
15:19How Alzheimer's disease prevalence could be associated with modifiable risk factors.
L
Listen to The Lancet Neurology
August issue highlights, including discussion of a genetic association study concerning intracerebral haemorrhage.
L
Listen to The Lancet Neurology
July issue highlights, including discussion of the EURAP Registry concerning a possible association between anti-epileptic drugs and congenital birth defects.
L
Listen to The Lancet Neurology
Bas Bloem discusses a review in the June issue about postural abnormalities associated with Parkinson's disease.
L
Listen to The Lancet Neurology
Discussion of new data from the ADAGIO trial for the treatment of Parkinson's disease, and a Canadian cohort study assessing risk factors for multiple sclerosis in children.
L
Listen to The Lancet Neurology
Highlights from the April issue with a focus on aneurysmal subarachnoid haemorrhage.
L
Listen to The Lancet Neurology
Highlights from the March issue with a focus on neurodegenerative disease.
L
Listen to The Lancet Neurology
Prozac and motor function after stroke, and the effect of rapid hypothermia after brain injury.
L
Listen to The Lancet Neurology
January highlights, including discussion of research from the TRACK-HD study for Huntington's disease.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: November 16, 2010 10:42
10:42
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
10:42Discussion of the RE-LY trial subgroup for the secondary prevention of stroke, and phase 2 results of gene therapy for Parkinson's disease.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: September 20, 2010 9:40
9:40
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
9:40October issue highlights, including cilostazol compared with aspirin for secondary stroke prevention.
L
Listen to The Lancet Neurology
September issue highlights, including the effects of a longer treatment window with alteplase after stroke, and discussion of a Review about ataxia.
L
Listen to The Lancet Neurology
The use of blood-pressure-lowering therapy after stroke, limbic encephalitis, and discussion of Huntington's disease prevalence.
L
Listen to The Lancet Neurology
July highlights, including ultrasound to detect asymptomatic carotid stenosis in stroke prevention.
L
Listen to The Lancet Neurology
June issue highlights, including discussion of depression and Parkinson's disease.
L
Listen to The Lancet Neurology
Lithium therapy and ALS, and stroke associated with Chaga's disease.
L
Listen to The Lancet Neurology
Discussion of April issue highlights, including the International Carotid Stenting study.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: February 18, 2010 10:33
10:33
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
10:33Discussion of concerns over generic substitution of antiepileptic drugs.
L
Listen to The Lancet Neurology
Alison Rowan discusses issue highlights, including PET imaging for the diagnosis of Parkinson's disease.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: December 14, 2009 12:52
12:52
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
12:52Kate Bushby discusses two reviews on Duchenne Muscular Dystrophy.
L
Listen to The Lancet Neurology
Discussion of the BENEFIT study for MS and the role of elderly people in neurological research.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: September 08, 2009 7:24
7:24
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
7:24Discussion of the CAVATAS trial for carotid stenosis.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: August 19, 2009 12:54
12:54
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
12:54Helen Frankish discusses articles about Huntington's disease and stroke.
L
Listen to The Lancet Neurology
Discussion of deep-brain stimulation for cerebral palsy, and rehabilitation interventions for motor recovery after stroke.
L
Listen to The Lancet Neurology
Alison Rowan discusses epilepsy services in the UK, and a review about CADASIL.
L
Listen to The Lancet Neurology
Helen Frankish discusses research on childhood stroke, and add-on drug therapy for MS.
L
Listen to The Lancet Neurology
Elena Becker-Barroso discusses the ISAT study follow-up, and paracetamol use in acute stroke.
L
Listen to The Lancet Neurology
Helen Frankish discusses the global incidence of stroke, and a research article assessing the malaria drug quinacrine for the treatment of prion disease.
L
Listen to The Lancet Neurology
Helen Frankish discusses articles on stroke prevention after TIA, and the potential of stem-cell therapy for the treatment of multiple sclerosis.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: January 19, 2009 10:00
10:00
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
10:00Helen Frankish discusses antipsychotics and Alzheimer's disease, and desmoteplase for ischaemic stroke.
L
Listen to The Lancet Neurology
Helen Frankish discusses articles about galantamine for severe Alzheimer's disease, and a genome-wide association study about CJD.
L
Listen to The Lancet Neurology
Helen Frankish discusses articles on NMDA-receptor encephalitis, perilesional brain oedema, and looks ahead to the TLN stroke conference in Beijing.
L
Listen to The Lancet Neurology
In this month's Lancet Neurology Podcast, Editor Helen Frankish discusses two research articles: one on the treatment of hemicrania continua, and another on perception of pain in a minimally conscious state. Also discussed is a review on sudden unexpected death in epilepsy.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: September 15, 2008 6:32
6:32
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
6:32Helen Frankish discusses highlights from the October issue, including follow-up results for trials comparing carotid stenting with endarterectomy in patients with stenosis; and the PRoFESS study comparing drug combinations to reduce the severity of recurrent ischaemic stroke.
L
Listen to The Lancet Neurology
Elena Becker-Barroso discusses highlights from the September issue, including the potential of PB2 to slow the development of amyloid beta in patients with Alzheimer's, and how telemedicine could improve stroke treatment.
L
Listen to The Lancet Neurology
Helen Frankish discusses biomarkers for indications of dementia, and other highlights from the August issue.
L
Listen to The Lancet Neurology
The International LRRK2 Consortium, which includes investigators in 21 centres, has collected data from almost 20000 patients with Parkinson's disease carrying mutations in the LRRK2 gene. The Lancet Neurology editor Elena Becker-Barroso and Daniel Healy, the corresponding author on their first report, summarises the findings and their implications in clinical practice in a podcast.…
L
Listen to The Lancet Neurology
Editor Helen Frankish discusses highlights from the June issue: a randomised trial showing the efficacy of a ketogenic diet to protect against childhood epilepsy; and a trial with phase II results for the Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease.
L
Listen to The Lancet Neurology
Editor Helen Frankish discusses highlights from the May issue: results from the INTERACT trial showing how intensive blood pressure lowering could be beneficial for people who have had intra cranial haemorrhage; also discussion of a genetic study identifying a gene mutation involved in amyloid lateral sclerosis, and a review of stroke in children.…
L
Listen to The Lancet Neurology
Editor Helen Frankish discusses highlights from the April issue: including the EPITHET study of alteplase treatment 3-6 hours after a stroke, and donepezil treatment in patients with CADASIL, a genetic form of vascular dementia.
L
Listen to The Lancet Neurology
Editor Helen Frankish discusses highlights from the March issue: including research Articles about a genetic clue to the cause of dystonia, a neurological disorder relating to Parkinson's disease; and a study identifying older age (68 years) as a risk factor for stroke among people given stenting rather than Endarterectomy to unblock the carotid artery.…
L
Listen to The Lancet Neurology
Imaging of amyloid β in Alzheimer's disease with a novel PET tracer Amyloid β (Aβ) deposits can be imaged by PET, but most Aβ PET ligands are not suitable for clinical diagnosis of Alzheimer's disease (AD). To test the effectiveness of a new Aβ PET ligand, 18F-BAY94-9172, Christopher Rowe and colleagues compared its binding with Aβ deposition in patients with AD, individuals with frontotemporal lobar degeneration, and healthy controls. Helen Frankish discusses the study in this month's podcast, and highlights the editorial concerning the possible tagging of individuals with AD.…
L
Listen to The Lancet Neurology
Epilepsy in children encompasses several syndromes that have different prognoses but are all characterised by a predisposition to recurrent seizures; therefore, treatment has to be tailored to the individual. Any treatment regimen for children with epilepsies should have rational goals, take into account the additional morbidities that are commonly found in these patients.…
L
Listen to The Lancet Neurology
Editor Helen Frankish discusses highlights from the December issue: original research investigating the efficacy of minocycline for the treatment of amyotrophic lateral sclerosis (ALS); a randomised trial assessing the effect and treatment duration of topiramate for the prevention of migraine; and a brief discussion of a review about medulloblastoma in children.…
L
Listen to The Lancet Neurology
Editor Helen Frankish discusses highlights from the November issue: two Articles looking at the early treatment of minor strokes or transient ischaemic attacks and the risk of stroke, an Editorial calling for more funding for headache research, and a large multinational study identifying genetic variants that influence the development of epilepsy.…
L
Listen to The Lancet Neurology
1 The Lancet Neurology: September 27, 2007 4:50
4:50
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
4:50Editor Helen Frankish discusses this month's leading edge editorial: the unsuccessful appeal against the UK National Institute for Health and Clinical Excellence (NICE) after its recent decision to not make dementia therapies widely available in the UK on grounds of cost-effectiveness
L
Listen to The Lancet Neurology
Editor Helen Frankish discusses highlights from the September issue: an association between Epstein-Barr virus and acquisition of multiple sclerosis in children; and current opportunities for the development of anti-epileptic drugs. Epilepsy and HIV are also discussed in this month's leading edge editorial.…
L
Listen to The Lancet Neurology
Editor Helen Frankish discusses two topics from the August issue: a research article suggesting people with epilepsy are three times more likely than the general population to commit suicide; and she interviews the author of a position paper about a new research framework for the diagnosis of Alzheimer's disease.…
L
Listen to The Lancet Neurology
In this month's Lancet Neurology podcast Helen Frankish discusses a research article concerning numerous factors which determine the risk of recurrent venous thromboembolism after cerebral venous thromboembolism in children. Also discussed is the Leading Edge editorial calling for a more modern approach to stroke services in the UK, and the review about silent infarcts, which could be a useful way of detecting neurological disease before symptoms develop.…
L
Listen to The Lancet Neurology
Editor Helen Frankish discusses highlights from the June issue: research from the University of Oxford about the incidence of haemorragic stroke; while incidence has decreased in younger age groups over the past two decades, inclusion of data from people aged over 75 years shows how overall incidence has remained the same, underlining the need for the inclusion of older people in stroke research. Also discussed is the comprehensive review on migraine and this month's editorial about stem-cell research in the USA.…
L
Listen to The Lancet Neurology
Editor Helen Frankish discusses highlights from the May issue. The GIST trial concerning blood glucose levels after stroke, despite being stopped early, has implications for future research in this area.
L
Listen to The Lancet Neurology
Editor Helen Frankish discusses the April issue, including promising research on occipital-nerve stimulation for cluster headache, and a new method to aid the diagnosis of Lewy body dementia.
L
Listen to The Lancet Neurology
Editor Helen Frankish discusses highlights from the March issue: a pooled analysis of three randomised trials which shows how decompression surgery soon after stroke onset can reduce mortality.
L
Listen to The Lancet Neurology
This month's podcast discusses the themed stroke issue coinciding with the International Stroke Conference taking place in San Francisco in early February. Also discussed is the first of a series of articles on stroke in developing countries.
L
Listen to The Lancet Neurology
Highlights from the January issue of The Lancet Neurology, includes a research article on epilepsy in sub-Saharan Africa and the Leading Edge urging WHO to prioritise neurological diseases.
L
Listen to The Lancet Neurology
December's Listen to The Lancet Neurology highlights the negative outcome of a trial of the drug TCH346 as a neuroprotective agent for Parkinson's disease, a Review about meningiomas, and depression among people with neurological disease.
L
Listen to The Lancet Neurology
Editor Helen Frankish discusses the highlights from the November issue, which this month has a focus on Parkinson's disease.
L
Listen to The Lancet Neurology
1 The Lancet Neurology: September 18, 2006 6:06
6:06
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
6:06October's TLN podcast includes a discussion of a paper on epilepsy in China, and a Forum article on possible infectious causes of multiple sclerosis.
Selamat datang di Player FM!
Player FM memindai web untuk mencari podcast berkualitas tinggi untuk Anda nikmati saat ini. Ini adalah aplikasi podcast terbaik dan bekerja untuk Android, iPhone, dan web. Daftar untuk menyinkronkan langganan di seluruh perangkat.